These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31447851)

  • 21. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
    Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
    Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of two recombinant HVT-IBD vaccines by VP2 insert detection and cell-mediated immunity after vaccination of specific pathogen-free chickens.
    Ingrao F; Rauw F; van den Berg T; Lambrecht B
    Avian Pathol; 2017 Jun; 46(3):289-299. PubMed ID: 27897452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective efficacy of a DNA vaccine construct encoding the VP2 gene of infectious bursal disease and a truncated HSP70 of Mycobacterium tuberculosis in chickens.
    Maity HK; Dey S; Mohan CM; Khulape SA; Pathak DC; Vakharia VN
    Vaccine; 2015 Feb; 33(8):1033-9. PubMed ID: 25596458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens.
    Wu J; Yu L; Li L; Hu J; Zhou J; Zhou X
    Plant Biotechnol J; 2007 Sep; 5(5):570-8. PubMed ID: 17561926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV.
    Richetta M; Gómez E; Lucero MS; Chimeno Zoth S; Gravisaco MJ; Calamante G; Berinstein A
    Vaccine; 2017 Jan; 35(1):142-148. PubMed ID: 27876199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chicken IL-7 as a potent adjuvant enhances IBDV VP2 DNA vaccine immunogenicity and protective efficacy.
    Huo S; Zuo Y; Li N; Li X; Zhang Y; Wang L; Liu H; Zhang J; Cui D; He P; Xu J; Li Y; Zhu X; Zhong F
    Vet Microbiol; 2016 Sep; 193():145-55. PubMed ID: 27599941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
    Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recombinant Vp2 protein of infectious bursal disease virus AH1 strain expressed in insect cells: a vaccine candidate].
    Ouyang W; Wang Y; Zhou Y; Zhang H; Tang Y
    Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):595-603. PubMed ID: 20684302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2.
    Li J; Liang X; Huang Y; Meng S; Xie R; Deng R; Yu L
    Virology; 2004 Nov; 329(1):89-100. PubMed ID: 15476877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity.
    Heine HG; Hyatt AD; Boyle DB
    Virus Res; 1994 Jun; 32(3):313-28. PubMed ID: 8079513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
    Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a T7 phage display nanobody library for bio-panning and identification of chicken dendritic cell-specific binding nanobodies.
    Xu H; Li L; Deng B; Hong W; Li R; Guo Z; Hou J; Govinden R; Chenia HY
    Sci Rep; 2022 Jul; 12(1):12122. PubMed ID: 35840654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens.
    Rong J; Jiang T; Cheng T; Shen M; Du Y; Li S; Wang S; Xu B; Fan G
    Vaccine; 2007 Nov; 25(46):7900-8. PubMed ID: 17923174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressing the immunodominant projection domain of infectious bursal disease virus fused to the fragment crystallizable of chicken IgY in yellow maize for a prospective edible vaccine.
    Salem R; Assem SK; Omar OA; Khalil AA; Basry MA; Waly FR; Samir N; El-Kholy AA
    Mol Immunol; 2020 Feb; 118():132-141. PubMed ID: 31881424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chicken bone marrow-derived dendritic cells maturation in response to infectious bursal disease virus.
    Liang J; Yin Y; Qin T; Yang Q
    Vet Immunol Immunopathol; 2015 Mar; 164(1-2):51-5. PubMed ID: 25613777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies.
    Li K; Liu Y; Zhang Y; Gao L; Liu C; Cui H; Qi X; Gao Y; Zhong L; Wang X
    Vet Immunol Immunopathol; 2017 Apr; 186():55-59. PubMed ID: 28413051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination with VP2 gene fragment confers protection against Infectious Bursal Disease Virus in chickens.
    Pradhan SN; Prince PR; Madhumathi J; Arunkumar C; Roy P; Narayanan RB; Antony U
    Vet Microbiol; 2014 Jun; 171(1-2):13-22. PubMed ID: 24745626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping.
    Wang XN; Zhang GP; Zhou JY; Feng CH; Yang YY; Li QM; Guo JQ; Qiao HX; Xi J; Zhao D; Xing GX; Wang ZL; Wang SH; Xiao ZJ; Li XW; Deng RG
    Viral Immunol; 2005; 18(3):549-57. PubMed ID: 16212534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.